Thoughts on AAO 2020: Uveitis Subspecialty Day


A uveitis specialist breaks down what occurs during the uveitis-dedicated event and comments on its importance.

Every other year, the American Academy of Ophthalmology (AAO) hosts a Uveitis Subspeciality Day as part of its larger conference agenda. The event allows ophthalmologists of all specialties and backgrounds an opportunity to stay up to date with the latest developments and trends in uveitis practice.

Events this year included sessions on anterior uveitis, panuveitis, and as well as a lecture on the future state of uveitis. One session featured talks on surgeries involving cataracts and glaucoma as well as specific case presentations.

In an interview with HCPLive®, Lynn Hassman, MD, PhD, Assistant Professor, Ophthalmology and Visual Sciences, Washington University School of Medicine, talked about the importance of the day for general ophthalmologists, trainees, and uveitis physicians.

“It’s very practical, but there are also tidbits there for practitioners at every level,” Hassman noted.

She explained that the meeting is run, proctored, and moderated by experts in the field with many years of experience.

Many of the cases presented during the meeting involved the most common uveitis scenarios encountered by virtually all ophthalmologists. From there, the presentations tackled other more in-depth topics — such as cases related to posterior uveitis and the retina.

The meeting also provided insight into how to properly diagnose cases, triage, and prescribe treatments.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.